Clinical Trial Update: Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors [NA]

View source ↗

Summary

A clinical trial evaluating whether methyl aminolevulinate cream can accurately mark the borders of basal cell carcinoma tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• m-ALA cream (methyl aminolevulinate cream)

Snippet

Sponsor: Assuta Hospital Systems | Conditions: Basal Cell Carcinoma | NA | Status: UNKNOWN